IDEXX Laboratories ROA 2012-2026 | IDXX
Current and historical return on assets (ROA) values for IDEXX Laboratories (IDXX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| IDEXX Laboratories ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $1.10B | $3.36B | 32.56% |
| 2025-12-31 | $1.06B | $3.32B | 31.92% |
| 2025-09-30 | $1.03B | $3.31B | 31.09% |
| 2025-06-30 | $0.99B | $3.30B | 29.90% |
| 2025-03-31 | $0.90B | $3.32B | 26.97% |
| 2024-12-31 | $0.89B | $3.35B | 26.48% |
| 2024-09-30 | $0.87B | $3.35B | 25.92% |
| 2024-06-30 | $0.85B | $3.28B | 25.80% |
| 2024-03-31 | $0.87B | $3.14B | 27.59% |
| 2023-12-31 | $0.85B | $3.01B | 28.11% |
| 2023-09-30 | $0.82B | $2.88B | 28.56% |
| 2023-06-30 | $0.79B | $2.77B | 28.59% |
| 2023-03-31 | $0.70B | $2.70B | 25.88% |
| 2022-12-31 | $0.68B | $2.65B | 25.65% |
| 2022-09-30 | $0.67B | $2.57B | 26.08% |
| 2022-06-30 | $0.66B | $2.51B | 26.50% |
| 2022-03-31 | $0.74B | $2.46B | 29.91% |
| 2021-12-31 | $0.75B | $2.39B | 31.17% |
| 2021-09-30 | $0.76B | $2.36B | 32.14% |
| 2021-06-30 | $0.73B | $2.27B | 32.07% |
| 2021-03-31 | $0.67B | $2.16B | 31.24% |
| 2020-12-31 | $0.58B | $2.05B | 28.43% |
| 2020-09-30 | $0.50B | $1.93B | 25.73% |
| 2020-06-30 | $0.46B | $1.86B | 24.76% |
| 2020-03-31 | $0.44B | $1.80B | 24.30% |
| 2019-12-31 | $0.43B | $1.75B | 24.50% |
| 2019-09-30 | $0.42B | $1.67B | 25.34% |
| 2019-06-30 | $0.41B | $1.62B | 25.16% |
| 2019-03-31 | $0.39B | $1.57B | 24.89% |
| 2018-12-31 | $0.38B | $1.52B | 24.84% |
| 2018-09-30 | $0.33B | $1.56B | 21.06% |
| 2018-06-30 | $0.31B | $1.59B | 19.27% |
| 2018-03-31 | $0.28B | $1.62B | 17.45% |
| 2017-12-31 | $0.26B | $1.65B | 15.96% |
| 2017-09-30 | $0.28B | $1.60B | 17.29% |
| 2017-06-30 | $0.26B | $1.56B | 16.79% |
| 2017-03-31 | $0.24B | $1.52B | 16.02% |
| 2016-12-31 | $0.22B | $1.50B | 14.74% |
| 2016-09-30 | $0.21B | $1.49B | 14.34% |
| 2016-06-30 | $0.20B | $1.48B | 13.58% |
| 2016-03-31 | $0.19B | $1.48B | 12.93% |
| 2015-12-31 | $0.19B | $1.47B | 13.11% |
| 2015-09-30 | $0.17B | $1.44B | 12.06% |
| 2015-06-30 | $0.18B | $1.40B | 13.04% |
| 2015-03-31 | $0.18B | $1.35B | 13.51% |
| 2014-12-31 | $0.18B | $1.31B | 13.95% |
| 2014-09-30 | $0.20B | $1.27B | 15.71% |
| 2014-06-30 | $0.19B | $1.24B | 15.53% |
| 2014-03-31 | $0.19B | $1.21B | 15.66% |
| 2013-12-31 | $0.19B | $1.18B | 15.92% |
| 2013-09-30 | $0.19B | $1.15B | 16.36% |
| 2013-06-30 | $0.19B | $1.12B | 16.47% |
| 2013-03-31 | $0.18B | $1.10B | 16.56% |
| 2012-12-31 | $0.18B | $1.08B | 16.46% |
| 2012-09-30 | $0.17B | $1.06B | 16.27% |
| 2012-06-30 | $0.17B | $1.03B | 16.38% |
| 2012-03-31 | $0.17B | $1.00B | 16.65% |
| 2011-12-31 | $0.16B | $0.97B | 16.89% |
| 2011-09-30 | $0.16B | $0.93B | 17.28% |
| 2011-06-30 | $0.16B | $0.91B | 17.35% |
| 2011-03-31 | $0.15B | $0.88B | 16.56% |
| 2010-12-31 | $0.14B | $0.85B | 16.51% |
| 2010-09-30 | $0.14B | $0.83B | 16.34% |
| 2010-06-30 | $0.13B | $0.82B | 16.21% |
| 2010-03-31 | $0.13B | $0.81B | 16.01% |
| 2009-12-31 | $0.12B | $0.80B | 15.40% |
| 2009-09-30 | $0.12B | $0.79B | 14.73% |
| 2009-06-30 | $0.11B | $0.78B | 14.13% |
| 2009-03-31 | $0.12B | $0.77B | 14.94% |
| 2008-12-31 | $0.12B | $0.76B | 15.36% |
| 2008-09-30 | $0.12B | $0.75B | 15.96% |
| 2008-06-30 | $0.12B | $0.72B | 16.54% |
| 2008-03-31 | $0.10B | $0.69B | 14.79% |
| 2007-12-31 | $0.10B | $0.67B | 14.24% |
| 2007-09-30 | $0.09B | $0.63B | 14.89% |
| 2007-06-30 | $0.09B | $0.59B | 15.65% |
| 2007-03-31 | $0.10B | $0.56B | 17.38% |
| 2006-12-31 | $0.09B | $0.52B | 18.24% |
| 2006-09-30 | $0.09B | $0.50B | 17.87% |
| 2006-06-30 | $0.09B | $0.49B | 17.35% |
| 2006-03-31 | $0.08B | $0.49B | 16.13% |
| 2005-12-31 | $0.08B | $0.49B | 16.02% |
| 2005-09-30 | $0.08B | $0.50B | 15.24% |
| 2005-06-30 | $0.08B | $0.50B | 14.90% |
| 2005-03-31 | $0.08B | $0.51B | 15.51% |
| 2004-12-31 | $0.08B | $0.52B | 15.25% |
| 2004-09-30 | $0.07B | $0.52B | 14.23% |
| 2004-06-30 | $0.07B | $0.52B | 13.56% |
| 2004-03-31 | $0.06B | $0.50B | 12.55% |
| 2003-12-31 | $0.06B | $0.48B | 11.86% |
| 2003-09-30 | $0.06B | $0.45B | 12.77% |
| 2003-06-30 | $0.05B | $0.43B | 12.48% |
| 2003-03-31 | $0.05B | $0.41B | 12.19% |
| 2002-12-31 | $0.05B | $0.40B | 11.26% |
| 2002-09-30 | $0.04B | $0.39B | 10.80% |
| 2002-06-30 | $0.04B | $0.38B | 10.62% |
| 2002-03-31 | $0.04B | $0.37B | 10.04% |
| 2001-12-31 | $0.04B | $0.35B | 10.84% |
| 2001-09-30 | $0.04B | $0.34B | 11.14% |
| 2001-06-30 | $0.04B | $0.34B | 10.91% |
| 2001-03-31 | $0.04B | $0.35B | 10.66% |
| 2000-12-31 | $0.04B | $0.36B | 10.36% |
| 2000-09-30 | $0.04B | $0.36B | 9.92% |
| 2000-06-30 | $0.04B | $0.37B | 9.45% |
| 2000-03-31 | $0.03B | $0.38B | 8.72% |
| 1999-12-31 | $0.03B | $0.39B | 8.31% |
| 1999-09-30 | $-0.01B | $0.39B | -1.78% |
| 1999-06-30 | $-0.01B | $0.39B | -2.30% |
| 1999-03-31 | $-0.01B | $0.39B | -3.11% |
| 1998-12-31 | $-0.02B | $0.38B | -3.91% |
| 1998-09-30 | $0.01B | $0.38B | 3.16% |
| 1998-06-30 | $-0.01B | $0.38B | -2.91% |
| 1998-03-31 | $-0.02B | $0.38B | -4.78% |
| 1997-12-31 | $-0.02B | $0.38B | -5.59% |
| 1997-09-30 | $-0.01B | $0.38B | -2.40% |
| 1997-06-30 | $0.02B | $0.37B | 4.59% |
| 1997-03-31 | $0.03B | $0.36B | 7.43% |
| 1996-12-31 | $0.03B | $0.35B | 9.40% |
| 1996-09-30 | $0.03B | $0.34B | 9.23% |
| 1996-06-30 | $0.03B | $0.32B | 8.38% |
| 1996-03-31 | $0.02B | $0.27B | 8.85% |
| 1995-12-31 | $0.02B | $0.22B | 9.36% |
| 1995-09-30 | $0.02B | $0.18B | 10.20% |
| 1995-06-30 | $0.02B | $0.13B | 13.08% |
| 1995-03-31 | $0.02B | $0.12B | 12.30% |
| 1994-12-31 | $0.01B | $0.12B | 12.23% |
| 1994-09-30 | $0.01B | $0.11B | 12.90% |
| 1994-06-30 | $0.01B | $0.10B | 12.68% |
| 1994-03-31 | $0.01B | $0.10B | 12.47% |
| 1993-12-31 | $0.01B | $0.09B | 10.99% |
| 1993-09-30 | $0.01B | $0.09B | 9.20% |
| 1993-06-30 | $0.01B | $0.08B | 8.41% |
| 1993-03-31 | $0.01B | $0.08B | 7.45% |
| 1992-12-31 | $0.01B | $0.07B | 7.04% |
| 1992-03-31 | $0.00B | $0.04B | 2.55% |
| 1991-06-30 | $0.00B | $0.03B | 9.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.716B | $4.304B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |